Antiphospholipid Syndrome
📧 Sign up to get email alerts when something new happens for Antiphospholipid Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
A clinical trial from The Chinese University of Hong Kong investigating the prevalence and etiologies of intracranial arterial stenosis in p…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
This clinical trial update describes a prospective cohort study comparing direct oral anticoagulants (DOACs) to vitamin K antagonists (VKAs)…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Negative Antiphospholipid Syndrome: a Multicentric Study
This multicenter clinical trial is recruiting to investigate management of Antiphospholipid Syndrome, including Seronegative Antiphospholipi…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs
An international observational study at Central Hospital, Nancy, France, evaluating antiphospholipid syndrome patients treated with direct o…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
This entry describes the Armenian nationwide registry of systemic autoimmune and autoinflammatory diseases, which is currently recruiting pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
This clinical trial update describes an ongoing Duke University study investigating genetic risk factors associated with Antiphospholipid Sy…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of zanubrutinib for antiphospholipid syndrome with secondary thrombocytopenia…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Effect of Belimumab on Antibody Titers in Primary APS Patients [Phase 2]
A Phase 2 clinical trial is evaluating belimumab for reducing antibody titers in primary antiphospholipid syndrome; the study is currently r…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases [NA]
A clinical trial update shows BRL-301 universal CAR-T cells from Bioray Laboratories enrolling (by invitation) for relapse or refractory aut…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE [Phase 4]
This Phase 4 clinical trial update describes a study comparing clopidogrel-based antiplatelet therapy versus warfarin for secondary preventi…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Safety and Efficiency of Sirolimus in Primary Antiphospholipid Syndrome: a Randomized Control Study [Phase 2]
Phase 2 randomized trial to evaluate the safety and efficacy of sirolimus in primary antiphospholipid syndrome; the study is currently not r…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks
A clinical trial in China recruiting to study antiphospholipid syndrome through collaborative networks.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
This clinical trial update covers the safety and potential efficacy of anti-CD19 CAR-T cells for relapsed/refractory autoimmune diseases, wi…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
A clinical trial is ongoing to study antiphospholipid syndrome in pregnancy and its potential postpartum pulmonary hypertension effects; the…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome [Phase 3]
Phase 3 trial evaluating hydroxychloroquine versus placebo for prevention of thrombotic relapse in primary antiphospholipid syndrome.
-
CLINICAL_TRIALS research · 2017-10-06Clinical Trial Update: Measurement of Anti-dsDNA by Both CLIFT & ELISA [NA]
A clinical trial update from Assiut University describes evaluating measurement of anti-dsDNA using CLIFT and ELISA in antiphospholipid synd…
-
CLINICAL_TRIALS research · 2015-01-21Clinical Trial Update: Pharmacogenetics of Warfarin in Puerto Ricans.
A completed clinical trial update examining the pharmacogenetics of warfarin in Puerto Rican participants and its implications for dosing in…
-
CLINICAL_TRIALS research · 2015-01-05Clinical Trial Update: Antiphospholipid Antibodies and Fetal Growth Restriction
This ClinicalTrials.gov entry describes a study investigating antiphospholipid antibodies in fetal growth restriction, sponsored by Saint Th…
-
CLINICAL_TRIALS research · 2015-01-05Clinical Trial Update: Antiphospholipid Antibodies and Early Severe Preeclampsia.
Clinical trial update related to antiphospholipid antibodies and early severe preeclampsia with an unknown status.
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
A clinical trial update investigating whether antiphospholipid antibodies affect the relationship between hyperuricemia, gout, and metabolic…